WO1995006417A1 - Dietary supplement based on soluble dietary fibers - Google Patents

Dietary supplement based on soluble dietary fibers Download PDF

Info

Publication number
WO1995006417A1
WO1995006417A1 PCT/DK1994/000258 DK9400258W WO9506417A1 WO 1995006417 A1 WO1995006417 A1 WO 1995006417A1 DK 9400258 W DK9400258 W DK 9400258W WO 9506417 A1 WO9506417 A1 WO 9506417A1
Authority
WO
WIPO (PCT)
Prior art keywords
dietary fibre
composition according
composition
treatment
dietary
Prior art date
Application number
PCT/DK1994/000258
Other languages
French (fr)
Inventor
Klaus KØHLER
Original Assignee
Sanacare Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanacare Aps filed Critical Sanacare Aps
Priority to EP94920413A priority Critical patent/EP0802737A1/en
Priority to AU71215/94A priority patent/AU7121594A/en
Publication of WO1995006417A1 publication Critical patent/WO1995006417A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27Xanthan not combined with other microbial gums
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/22Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/68Plantaginaceae (Plantain Family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats

Definitions

  • the invention relates to a drinkable dietary fibre composition for mixing in cold water.
  • dietary fibre is "macromolecules of vegetable origin characterized by the fact that they are not degraded by the human digestion enzymes". Dietary fibres may be divided into two main groups - the soluble and the insoluble ones. These are very different relating to physical-chemical and nutritional properties. The insoluble dietary fibres that for instance are found in coarse bread and bran possess a certain laxative effect and probably prevent colon cancer. It is relatively easy to increase the consumption of insoluble dietary fibres for instance by changing from fine to more coarse sorts of bread in the daily diet.
  • the soluble dietary fibres also have these beneficial properties but are in addition assumed to have other beneficial therapeutical and preventive properties in relation to increased serum cholesterol, diabetes and obesity.
  • An increase of one's consumption of soluble dietary fibres through dietary changes is no simple matter because die contents of normal foods are relatively low. For that reason a radical change of the diet is needed - something that notoriously is difficult to many people to go through with in practice.
  • a dietary supplement based on soluble dietary fibre therefore is highly justified.
  • Tablets are not suitable as pharmaceutical formulations because rather large amounts of soluble dietary fibre are to be consumed to achieve d e beneficial effects (10-30 gram per day according to J.W. Anderson et al.: “Dietary fibre. Chemistry, Physiology and Health Effects. ", 1990 Plenum Press, New York, p. 339-63). "Nutritional guidelines for health education in Germany” recommends 30 gram per day (Nutr. Today, 21, 21, 1986). In addition it is difficult to achieve a sufficient release of the fibres from a tablet.
  • a drinkable dietary fibre composition d erefore is the preferred dietary supplement based on soluble dietary fibre. The fluid supply is also ensured which is necessary for the soluble dietary fibre to carry out their beneficial effect.
  • a dietary supplement is to be of beneficial value it is not sufficient to have a composition which is optimal with respect to the composition of the dietary fibres.
  • the product also has to be organoleptically attractive, as it is to be consumed daily for many years. Soluble dietary fibre present in this case the particular problem of a tendency to form highly viscous aqueous solutions.
  • highly viscous drinks are regarded as unappetizing by many consumers. It is therefore important for the sake of the organoleptic impression to try to keep the viscosity low until the drink has been consumed.
  • a dispersion where the still undissolved particles after dispersion in water distribute evenly in the liquid therefore is preferred from an organoleptic point of view.
  • Water soluble hydrolysed starch oligosaccharide here is defined as a starch hydrolysed by d e application of either acids or enzymes.
  • the film is applied by spraying of either starch oligosaccharide, polyglycose, or polymaltose dissolved in water.
  • the usual method of applying a such film will be to apply a finely sprayed solution via a nozzle while e particles are kept in a steady motion, typical in a so called fluidized bed. It appears from the patent that this is the method of application thought of. To make ⁇ ese conventional methods of application work the liquid to be applied must have a low viscosity, otherwise a sufficient spray condition will not be obtained.
  • US Patent 5,118,510 relates to a water dispersable fibre containing mixture consisting of among other ingredients a gel forming dietary fibre and an edible acid. The granulates formed are coated with a gel forming component.
  • the mixture contains a mineral salt releasing a physiologically acceptable gas after administration of die dispersed fibre-mixture as well as a pharmaceutically active compound.
  • US Patent 4,824,672 relates to an edible composition that contains a gel forming fibre able to lower serum cholesterol. The composition also contains a mineral salt which by dissolution in the stomach releases a gas (carbon dioxide).
  • US Patent 4,551,331 relates to a dietary fibre composition which is easily dispersed in water. This effect is obtained by coating the dietary fibre with 0.05-20% of an emulsifier suitable for the use in foods. These emulsifiers normally will be of a fatty substance character Thus they will, when they are distributed over a large surface, have a tendency to go rancid.
  • the present invention relates to dietary fibre particles of which a granulate is produced which in addition contains 1-10% of an easily soluble acid being acceptable in foods and 2-25 % of one or more thickening agents characterized by easily dissolving in cold water.
  • Preferred types of dietary fibre are psyllium husk as well as combinations of psyllium husk wim one or more of the following: guar gum, glucomannan, karaya gum, locust bean gum, and xanman gum, where psyllium husk constitutes at least 40%.
  • the most preferred acids are malic acid and citric acid.
  • the most preferred thickening agents are guar gum, xanthan gum, locust bean gum, and pregelatinised starch.
  • pregelatinised starch is a starch which has been boiled and subsequently dried. Therefore it is a starch which has not gone through a hydrolysis widi acid or enzymes.
  • the granulation takes place during spraying with liquid.
  • some of die powdery ingredients preferably the thickening agents, may be powdered on to the surface of the moist granules. By this powdering a quicker release of the diickening effect is also achieved. Subsequently the granules are dried, f.inst. in a fluidized bed.
  • Vitamins and minerals can be added to me product.
  • the organoleptical quality may be improved by the addition of suitable flavours and colorants. Preferred are fruit flavours like orange and odier citrus fruits as well as various tropical fruits like papaya.
  • the dietary fibre particles become easily dispersable in water and a reduction of the sedimentation rate without an unacceptably high viscosity within normal drinking time is achieved.
  • the fibre composition will give a drink very much like fresh fruit juice with a certain content of fruit pulp, in particular when suitable flavours and colorants have been added.
  • the citric acid adds a fresh taste to the drink. This makes the fibre drink more organoleptically appealing than it has been possible to obtain through any of the so far described methods.
  • the citric acid have a certain preservative effect. Through a number of combinations of different dietary fibre sources a synergistic effect of thickening may be obtained.
  • psyllium husk Preferred are combinations of psyllium husk and one or more of the following: guar gum, glucomannan, karaya gum, locust bean gum, and xanthan gum. Most preferred are such combinations wherein psyllium husk constitutes 40-90% of the mixture.
  • ti at a composition according to die invention is very suitable in the treatment of a number of diseases like diabetes, in particular NIDDM (type II), conditions of hyperlipidaemia, preferably caused by a too high serum concentration of LDL cholesterol, as well as in the treatment of overweight, in particular through regulation of the appetite of persons suffering from overweight.
  • diseases like diabetes, in particular NIDDM (type II)
  • conditions of hyperlipidaemia preferably caused by a too high serum concentration of LDL cholesterol
  • overweight in particular through regulation of the appetite of persons suffering from overweight.
  • aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
  • the aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
  • the resulting granulate is subsequently dried in a fluidized bed of conventional type.
  • the aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
  • the resulting granulate is subsequently dried in a fluidized bed of conventional type.
  • beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
  • the aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
  • the aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
  • the resulting granulate is subsequently dried in a fluidized bed of conventional type.
  • beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
  • the aqueous solution is sprayed onto die powder mixture in die intensive mixer in a fine mist while intensively mixing the powder mixture.
  • the resulting granulate is subsequently dried in a fluidized bed of conventional type.
  • the aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
  • composition corresponding to 4.4 gram of soluble fibre is suspended in 150 ml of tap water having a temperature of appr. 12 deg. C. Suspension is carried out for 30 seconds. Subsequently the suspension is characterised with respect to the following parameters: 1) Dispersability and wettability of the granulate.
  • the viscosity is measured after stirring at 2, 5, 10 and 20 minutes.
  • wetted drinkable dietary fibre product 6.2 g good easily more than 5 min. according to example 3 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 4 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 5 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 6 wetted
  • Table 2 Change in viscosity as a function of time for a number of concentrated sources of soluble dietary fibre, dispersed in water. It appears from table 1 and 2 that die dietary fibre compositions prepared according to die invention fulfils the demands of good dispersability, slow precipitation and sufficiently slow increase in viscosity after dispersion in water.
  • Criteria of inclusion Age 20-70 years, sex: Male or Female, total cholesterol >7.0 mmol/1, serum ⁇ -iglycerides less than 5 mmol/1.
  • Criteria of exclusion Possible secondary hyperlipidaemia, severe overweight, (BMI more than 32.5), alcohol consumption more man 5 drinks per day, use of drugs, interfering with serum cholesterol, suspicion of insufficient compliance, other serious diseases.
  • Treatment The first 4 weeks served as a run-in period. The purpose partly was to give a more reliable determination of the initial test values and partly to compensate for the well known fact diat persons often change behaviour when entering into a clinical investigation.
  • the treatment had a duration of two periods of 4 weeks each.
  • Patients 30 patients were selected according to die following criteria of inclusion and exclusion and randomised into two groups of the same size. Criteria of inclusion: 18 - 75 years of age, sex: male and female, non-insulin- dependent diabetics under treatment with diet and tablets.
  • Criteria of exclusion Possible secondary hyperlipidaemia, alcohol consumption exceeding 5 drinks a day, use of drugs which may Interfere with the monitored parameters, suspicion of insufficient compliance, liver-diseases, pregnancy, intolerance to aspartame, creatinine more than 0.120 mmol/1 or albuminuria, psychotic subjects or subjects suffering from dementia, rise in blood-pressure demanding medical treatment during the investigation.
  • Treatment The two first weeks served as a run-in period. The purpose partly was to give a more reliable determination of the initial test values and partly to compensate for the well known fact that persons often change their behaviour when entering into a clinical investigation. After the run-in period a blood sample was taken and blood pressure and body weight were measured.
  • blood samples for the analysis of serum cholesterol, blood sugar, HbAlc, serum calcium, triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol were taken.
  • Patients 30 patients were selected according to the following criteria of inclusion and exclusion and randomised into two groups of the same size. Criteria of inclusion: 18 - 75 years of age, sex: male and female, non-insulin- dependent diabetics under treatment with diet and tablets.
  • Criteria of exclusion Possible secondary hyperlipidaemia, alcohol consumption exceeding 5 drinks a day, use of drugs which may interfere with the monitored parameters, suspicion of insufficient compliance, liver-diseases, pregnancy, intolerance to aspartame, creatinine more than 0.120 mmol/1 or albuminuria, psychotic subjects or subjects suffering from dementia, rise in blood-pressure demanding medical treatment during the investigation.
  • Treatment The two first weeks served as a run-in period. The purpose partly was to give a more reliable determination of die initial test values and partly to compensate for the well known fact that persons often change their behaviour when entering into a clinical investigation. After the run-in period a blood sample was taken and blood pressure and body weight were measured.

Abstract

Dietary fibre composition and drink made from the composition with a high content of soluble dietary fibre, wherein the dispersability is improved, and the rate of sedimentation is reduced. The dietary fibre composition consists of granulate particles coated with modified starch.

Description

DIETARY SUPPLEMENT BASED ON SOLUBLE DIETARY FIBERS.
The invention relates to a drinkable dietary fibre composition for mixing in cold water.
A suitable definition of the concept "dietary fibre" is "macromolecules of vegetable origin characterized by the fact that they are not degraded by the human digestion enzymes". Dietary fibres may be divided into two main groups - the soluble and the insoluble ones. These are very different relating to physical-chemical and nutritional properties. The insoluble dietary fibres that for instance are found in coarse bread and bran possess a certain laxative effect and probably prevent colon cancer. It is relatively easy to increase the consumption of insoluble dietary fibres for instance by changing from fine to more coarse sorts of bread in the daily diet.
The soluble dietary fibres also have these beneficial properties but are in addition assumed to have other beneficial therapeutical and preventive properties in relation to increased serum cholesterol, diabetes and obesity. An increase of one's consumption of soluble dietary fibres through dietary changes is no simple matter because die contents of normal foods are relatively low. For that reason a radical change of the diet is needed - something that notoriously is difficult to many people to go through with in practice. A dietary supplement based on soluble dietary fibre therefore is highly justified.
Prior art;
Tablets are not suitable as pharmaceutical formulations because rather large amounts of soluble dietary fibre are to be consumed to achieve d e beneficial effects (10-30 gram per day according to J.W. Anderson et al.: "Dietary fibre. Chemistry, Physiology and Health Effects. ", 1990 Plenum Press, New York, p. 339-63). "Nutritional guidelines for health education in Britain" recommends 30 gram per day (Nutr. Today, 21, 21, 1986). In addition it is difficult to achieve a sufficient release of the fibres from a tablet. A drinkable dietary fibre composition d erefore is the preferred dietary supplement based on soluble dietary fibre. The fluid supply is also ensured which is necessary for the soluble dietary fibre to carry out their beneficial effect. If a dietary supplement is to be of beneficial value it is not sufficient to have a composition which is optimal with respect to the composition of the dietary fibres. The product also has to be organoleptically attractive, as it is to be consumed daily for many years. Soluble dietary fibre present in this case the particular problem of a tendency to form highly viscous aqueous solutions. However, highly viscous drinks are regarded as unappetizing by many consumers. It is therefore important for the sake of the organoleptic impression to try to keep the viscosity low until the drink has been consumed.
An obvious method to achieve this is to agglomerate the fibre particles. The smaller surface thus obtained leads to a slower absorption of water so the viscosity of the aqueous phase increases more slowly. A drawback at this method is, however, that fibre agglomerates after dissolution in a glass of water will gather as slimy and unappetizing lumps on the bottom of the glass. Ingestion of those lumps will give an unpleasant feeling in the mouth.
A dispersion, where the still undissolved particles after dispersion in water distribute evenly in the liquid therefore is preferred from an organoleptic point of view. The finer the particles are the easier they will stay dispersed in d e liquid without precipitating. On the other hand the finer the particles are, the faster will they dissolve and result in an increase in the viscosity. Also there will be a tendency towards very fine particles being difficult to disperse as they may be difficult to wet. They will tend to stay undissolved on top of the liquid phase.
Accordingly such a composition will be inappropriate to ingest. The problem with the poor dispersability in a number of commercial products based on psyllium husk is solved by adding of large amounts of sugar, typically around 50%. By this a certain improvement of taste is achieved together with some improvement of the dispersability. The use of those large amounts of sugar might be questionable f.inst. in the treatment of diabetics or persons with a need of reducing their weight. Also the problem of keeping the particles dispersed without precipitating too fast is not solved satisfactory by this method. In US Patent 3,455,714 a method of improving me dispersability of water soluble cellulose derivatives and water soluble gums by a coating of cellulose derivatives is described. However, in general these are not accepted in foods according to the food regulations in most European countries and North America. Also this method does not keep the particles from precipitating too fast. In US Patent 4,459,280 a method of increasing the dispersability of psyllium husk by applying a film consisting of water soluble hydrolysed starch oligosaccharide, a polyglucose or a poly maltose is described.
Water soluble hydrolysed starch oligosaccharide here is defined as a starch hydrolysed by d e application of either acids or enzymes. The film is applied by spraying of either starch oligosaccharide, polyglycose, or polymaltose dissolved in water. The usual method of applying a such film will be to apply a finely sprayed solution via a nozzle while e particles are kept in a steady motion, typical in a so called fluidized bed. It appears from the patent that this is the method of application thought of. To make Λese conventional methods of application work the liquid to be applied must have a low viscosity, otherwise a sufficient spray condition will not be obtained. This of course could be obtained with every water soluble substance through sufficient dilution. The application of such a strongly diluted solutions however will influence the economy of the process infavourably, as for a given amount of applied film it will be necessary to evaporate huge amounts of water. Also the processing time will be unacceptably long. Thus it is also mentioned in US Patent 4,459,280 that at least 7-8% dry matter in the applied solution is aimed. US Patent 5,118,510 relates to a water dispersable fibre containing mixture consisting of among other ingredients a gel forming dietary fibre and an edible acid. The granulates formed are coated with a gel forming component. Further the mixture contains a mineral salt releasing a physiologically acceptable gas after administration of die dispersed fibre-mixture as well as a pharmaceutically active compound. US Patent 4,824,672 relates to an edible composition that contains a gel forming fibre able to lower serum cholesterol. The composition also contains a mineral salt which by dissolution in the stomach releases a gas (carbon dioxide). US Patent 4,551,331 relates to a dietary fibre composition which is easily dispersed in water. This effect is obtained by coating the dietary fibre with 0.05-20% of an emulsifier suitable for the use in foods. These emulsifiers normally will be of a fatty substance character Thus they will, when they are distributed over a large surface, have a tendency to go rancid. The degradation products, which arise when fats go rancid, have a very unpleasant smell and taste, also in very small amounts. As appears from the above mentioned examination of the prior art this does not provide a method for the preparation of a drinkable dietary fibre composition which on one hand contains an effective dose of soluble dietary fibre and on the other hand when mixing in water gives a dispersion with slow precipitation and low viscosity at d e moment of drinking.
The present invention relates to dietary fibre particles of which a granulate is produced which in addition contains 1-10% of an easily soluble acid being acceptable in foods and 2-25 % of one or more thickening agents characterized by easily dissolving in cold water. Preferred types of dietary fibre are psyllium husk as well as combinations of psyllium husk wim one or more of the following: guar gum, glucomannan, karaya gum, locust bean gum, and xanman gum, where psyllium husk constitutes at least 40%. The most preferred acids are malic acid and citric acid. The most preferred thickening agents are guar gum, xanthan gum, locust bean gum, and pregelatinised starch. According to "Dictionary of Nutrition and Food Technology "(Ed.: Arnold E. Bender) pregelatinised starch is a starch which has been boiled and subsequently dried. Therefore it is a starch which has not gone through a hydrolysis widi acid or enzymes.
The granulation takes place during spraying with liquid. To keep the moist granules from agglomerating some of die powdery ingredients, preferably the thickening agents, may be powdered on to the surface of the moist granules. By this powdering a quicker release of the diickening effect is also achieved. Subsequently the granules are dried, f.inst. in a fluidized bed. The advantage of this process compared to the prior art is that the use of a solvent is avoided. Vitamins and minerals can be added to me product. The organoleptical quality may be improved by the addition of suitable flavours and colorants. Preferred are fruit flavours like orange and odier citrus fruits as well as various tropical fruits like papaya. With a composition according to the invention the dietary fibre particles become easily dispersable in water and a reduction of the sedimentation rate without an unacceptably high viscosity within normal drinking time is achieved. When mixed widi cold water the fibre composition will give a drink very much like fresh fruit juice with a certain content of fruit pulp, in particular when suitable flavours and colorants have been added. The citric acid adds a fresh taste to the drink. This makes the fibre drink more organoleptically appealing than it has been possible to obtain through any of the so far described methods. At the same time the citric acid have a certain preservative effect. Through a number of combinations of different dietary fibre sources a synergistic effect of thickening may be obtained.
Preferred are combinations of psyllium husk and one or more of the following: guar gum, glucomannan, karaya gum, locust bean gum, and xanthan gum. Most preferred are such combinations wherein psyllium husk constitutes 40-90% of the mixture.
Further it has been found ti at a composition according to die invention is very suitable in the treatment of a number of diseases like diabetes, in particular NIDDM (type II), conditions of hyperlipidaemia, preferably caused by a too high serum concentration of LDL cholesterol, as well as in the treatment of overweight, in particular through regulation of the appetite of persons suffering from overweight.
The following examples serve to illustrate the invention. Example 1
In an intensive mixer the following ingredients are mixed dry:
Psyllium husk (BP 80) 17.500 kg glucomannan (95%) 0.250 kg guar gum (Indian guar gum HV) 4.550 kg citric acid (anhydrous) 1.230 kg
Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre The aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in the intensive mixer under intensive mixing.
The resulting granulate is subsequently dried in a fluidized bed of conventional type.
Example 2
In an intensive mixer the following ingredients are mixed dry: Psyllium husk (BP 80) 17.500 kg glucomannan (95%) 0.250 kg guar gum (Indian guar gum HV) 4.550 kg citric acid (anhydrous) 1.230 kg Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
The aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in the intensive mixer under intensive mixing.
The resulting granulate is subsequently dried in a fluidized bed of conventional type.
Example 3
In an intensive mixer the following ingredients are mixed dry:
Psyllium husk (BP 80) 17.150 kg karaya gum 2.860 kg guar gum (Indian guar gum HV) 1.140 kg xandian gum (Meyhall) 1.140 kg
Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
The aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in the intensive mixer under intensive mixing.
The resulting granulate is subsequently dried in a fluidized bed of conventional type. Example 4
In an intensive mixer the following ingredients are mixed dry:
Psyllium husk (BP 80) 17.340 kg karaya gum 1.900 kg glucomannan 0.760 kg guar gum (Indian guar gum HV) 1.140 kg xanthan gum (Meyhall) 1.140 kg Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
The aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in the intensive mixer under intensive mixing.
The resulting granulate is subsequently dried in a fluidized bed of conventional type.
Example 5
In an intensive mixer the following ingredients are mixed dry:
Psyllium husk (BP 80) 18.110 kg glucomannan 1.910 kg guar gum (Indian guar gum HV) 1.140 kg xanthan gum (Meyhall) 1.140 kg
Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
The aqueous solution is sprayed onto die powder mixture in die intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in the intensive mixer under intensive mixing.
The resulting granulate is subsequently dried in a fluidized bed of conventional type.
Example 6
In an intensive mixer the following ingredients are mixed dry: Psyllium husk (BP 80) 17.500 kg glucomannan (95%) 0.250 kg guar gum (Indian guar gum HV) 4.550 kg citric acid (anhydrous) 1.230 kg Subsequently an aqueous solution of the following composition is prepared: beta-carotene 1 % (CWD, Hoffmann La Roche) 0.360 kg aspartame 0.280 kg demineralized water, 45 deg. C 4.500 litre
The aqueous solution is sprayed onto the powder mixture in the intensive mixer in a fine mist while intensively mixing the powder mixture.
Subsequently 3.800 kg of pregelatinised potato starch is added to the wetted powder mixture in die intensive mixer under intensive mixing. The resulting granulate is subsequently dried in a fluidized bed of conventional type. Example 7
To illustrate the invention quantitative and qualitative characterisations are carried out with a number of compositions prepared according to die invention, and compared to a number of compositions known from the prior art.
Materials and methods: An amount of the composition corresponding to 4.4 gram of soluble fibre is suspended in 150 ml of tap water having a temperature of appr. 12 deg. C. Suspension is carried out for 30 seconds. Subsequently the suspension is characterised with respect to the following parameters: 1) Dispersability and wettability of the granulate.
2) Precipitation of the granulate.
3) Change in viscosity as function of time at room temperature (22 deg. C)
Measurements of viscosity are carried out using a "Brookfield Viscosimeter", Model
HAT.
The viscosity is measured after stirring at 2, 5, 10 and 20 minutes.
Results:
Amount Dispersability Period during in 150 which appr. half
Product ml of of the particles water has precipitated after stirring
Psyllium husk, BP 88 5.0 g bad, floating, less than 30 sec. wetted only slowly glucomannan, commercial 5.0 g good, easily less than 30 sec. product wetted guar gum (commercial 5.0 g bad, floating, _* product) forms lumps commercial product consisting 8.9 g good, wetted less than 30 sec. of 50% saccharose and 50% rather easily psyllium husk guar granules (commercial 5.0 g good, wetted less dian 15 sec. product) radier easily drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 1 wetted drinkable dietary fibre product 6.2 g good, easily more man 5 min. according to example 2 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 3 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 4 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 5 wetted drinkable dietary fibre product 6.2 g good, easily more than 5 min. according to example 6 wetted
The particles dissolve very fast after dispersion and do not precipitate. Table 1: Wettability, dispersability and tendency to precipitate for a number of concentrated sources of soluble dietary fibre. Results:
amount in 2 min. 5 min. 10 min. 20 min.
Product 150 ml of cP cP cP cP water
Psyllium husk, 5.0 g 200 320 820 1520 BP 88 glucomannan, 5.0 g 20 60 380 17000 95 %, commercial product guar gum 5.0 g 5000 26000 - -
(commercial product) commercial 8.9 g 160 660 1580 1920 product consisting of 50% saccharose and 50% psyllium husk guar granules 5.0 g 40* 40* 120* 440*
(commercial product) drinkable dietary 6.2 g 20 140 680 3800 fibre product according to example 1 drinkable dietary 6.2 g 15 130 860 4200 fibre product according to example 2
* Disintegrates only to a minor degree.
Table 2: Change in viscosity as a function of time for a number of concentrated sources of soluble dietary fibre, dispersed in water. It appears from table 1 and 2 that die dietary fibre compositions prepared according to die invention fulfils the demands of good dispersability, slow precipitation and sufficiently slow increase in viscosity after dispersion in water.
Measurements in artificial intestinal juice show that the dietary fibre compositions according to the invention provide a high viscosity (4-11000 cP after 8 hours) to the artificial intestinal juice (calibrated widi buffer to a pH of 7.5). Example 8
A clinical trial was carried out with the purpose of investigating the serum cholesterol lowering effect of the dietary fibre composition.
Patients: 20 patients who had all for a longer period of time been on a diet with the purpose of reducing dieir serum cholesterol (max. 30 energy % fat, max. 10 energy % from saturated fat, max. 300 mg cholesterol per day), but whose serum cholesterol level still was so high that a further lowering was desirable were included in die study. The other criteria of inclusion and exclusion were:
Criteria of inclusion: Age 20-70 years, sex: Male or Female, total cholesterol >7.0 mmol/1, serum ϋ-iglycerides less than 5 mmol/1.
Criteria of exclusion: Possible secondary hyperlipidaemia, severe overweight, (BMI more than 32.5), alcohol consumption more man 5 drinks per day, use of drugs, interfering with serum cholesterol, suspicion of insufficient compliance, other serious diseases.
Treatment: The first 4 weeks served as a run-in period. The purpose partly was to give a more reliable determination of the initial test values and partly to compensate for the well known fact diat persons often change behaviour when entering into a clinical investigation.
For instance the patients might change their food intake which could lead to a change in serum cholesterol.
After the run-in period a blood sample was taken.
Subsequently the subjects passed on to a treatment with a dietary fibre composition prepared according to the invention.
The patients took 5.5 gram of the composition stirred into approximately 150 ml of water 3 times a day with the meals.
The treatment had a duration of two periods of 4 weeks each.
By the termination of each of tiiose periods die patients among other things were asked about dieir compliance. Compliance also was measured by counting returned test materials.
Also blood samples for analysis of serum cholesterol were taken.
Results: One patient had to be excluded due to dementia and three due to bad compliance. For die remaining 16 patients a significant drop in total serum cholesterol of 13% (from a mean value of 8.7 mmol/1 to 7.6 mmol/1, p less than 0.05) was found after both 4 and 8 weeks of treatment when compared to the values found after the termination of the run-in period. A good compliance (more than 90 %) was found. During the run-in period the total serum cholesterol did not change. Example 9
A clinical trial was carried out with the purpose of investigating the value of the dietary fibre composition in the treatment of diabetes.
Patients: 30 patients were selected according to die following criteria of inclusion and exclusion and randomised into two groups of the same size. Criteria of inclusion: 18 - 75 years of age, sex: male and female, non-insulin- dependent diabetics under treatment with diet and tablets.
Criteria of exclusion: Possible secondary hyperlipidaemia, alcohol consumption exceeding 5 drinks a day, use of drugs which may Interfere with the monitored parameters, suspicion of insufficient compliance, liver-diseases, pregnancy, intolerance to aspartame, creatinine more than 0.120 mmol/1 or albuminuria, psychotic subjects or subjects suffering from dementia, rise in blood-pressure demanding medical treatment during the investigation. Treatment: The two first weeks served as a run-in period. The purpose partly was to give a more reliable determination of the initial test values and partly to compensate for the well known fact that persons often change their behaviour when entering into a clinical investigation. After the run-in period a blood sample was taken and blood pressure and body weight were measured.
Subsequently the subjects passed on to a treatment with a dietary fibre composition prepared according to me invention.
The patients took 5.5 gram of the composition or a placebo-composition based on insoluble dietary fibre stirred into in approximately 150 ml of water 3 times a day widi the meals. The treatment had a duration of two periods of 4 weeks each. By the termination of each of diose periods the patients among other diings were asked about their compliance. Compliance also was measured by counting returned test materials. Blood pressure and body weight were measured. Also blood samples for the analysis of serum cholesterol, blood sugar, HbAlc, serum calcium, triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol were taken.
Results: The results of this double-blinded placebo-controlled study showed that treatment with the dietary fibre composition had a good effect in the treatment of diabetes. Example 10
A clinical trial was carried out with the purpose of investigating the value of the dietary fibre composition in the treatment of overweight.
Patients: 30 patients were selected according to the following criteria of inclusion and exclusion and randomised into two groups of the same size. Criteria of inclusion: 18 - 75 years of age, sex: male and female, non-insulin- dependent diabetics under treatment with diet and tablets.
Criteria of exclusion: Possible secondary hyperlipidaemia, alcohol consumption exceeding 5 drinks a day, use of drugs which may interfere with the monitored parameters, suspicion of insufficient compliance, liver-diseases, pregnancy, intolerance to aspartame, creatinine more than 0.120 mmol/1 or albuminuria, psychotic subjects or subjects suffering from dementia, rise in blood-pressure demanding medical treatment during the investigation. Treatment: The two first weeks served as a run-in period. The purpose partly was to give a more reliable determination of die initial test values and partly to compensate for the well known fact that persons often change their behaviour when entering into a clinical investigation. After the run-in period a blood sample was taken and blood pressure and body weight were measured.
Subsequently the subjects passed on to a treatment with a dietary fibre composition prepared according to the invention.
The patients took 5.5 gram of the composition or a placebo-composition based on insoluble dietary fibre stirred into in approximately 150 ml of water 3 times a day in connection with the meals. The treatment had a duration of two periods of 4 weeks each.
By the termination of each of those periods the patients among odier diings were asked about dieir compliance. Compliance also was measured by counting returned test materials. Blood pressure and body weight were measured. Also blood samples for analysis of serum cholesterol, blood sugar, HbAlc, serum calcium, triglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol were taken.
Results: The results of this double-blinded placebo-controlled study showed that treatment with die dietary fibre composition had a good effect in the treatment of overweight.

Claims

CLAIMS A composition comprising one or more kinds of soluble dietary fibre
CHARACTERIZED IN that the dietary fibre are granulated with an edible acid and a modified starch.
2. A drink composed of in particular water and a readily dispersable granule material CHARACTERIZED IN that the granule material is a composition according to claim 1.
3. Use of a composition according to claim 1-2 for the preparation of a medicament in the treatment of hyperlipidaemia.
4. Use of a composition according to claim 1-2 for the preparation of a medicament in the treatment of diabetes.
5. Use of a composition according to claim 1-2 for the preparation of a medicament in the treatment of overweight.
6. A composition according to claim 1 wherein the modified starch is pregelatinised starch.
7. A composition according to claim 1 wherein the soluble dietary fibre are selected from the group consisting of psyllium husk, guar gum, glucomannan, karaya gum, locust bean gum and xanthan gum.
8. A composition according to claim 1 CHARACTERIZED IN that psyllium husk , glucomannan and guar gum are granulated with citric acid and pregelatinised starch from potato.
9. A process for the preparation of a composition according to claim 1 CHARACTERIZED IN a) a dry mixing of one or more kinds of soluble dietary fibre with an edible acid, b) spraying of the dry mix thereby formed with water and excipients under intensive mixing, c) addition of powdery modified starch to the moistened powder mix under intensive mixing and d) drying of the wet granulate so formed in a fluidized bed to form a granulate according to claim 1.
10. Administration of a medicament according to one of die claims 3-5 CHARACTERIZED IN that the administered amount of dietary fibre is from 1 to 25 gram per day.
PCT/DK1994/000258 1993-09-02 1994-06-24 Dietary supplement based on soluble dietary fibers WO1995006417A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP94920413A EP0802737A1 (en) 1993-09-02 1994-06-24 Dietary supplement based on soluble dietary fibers
AU71215/94A AU7121594A (en) 1993-09-02 1994-06-24 Dietary supplement based on soluble dietary fibers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK9300398U DK9300398U3 (en) 1993-09-02 1993-09-02 Drinkable dietary fiber composition
DK9300398 1993-09-02

Publications (1)

Publication Number Publication Date
WO1995006417A1 true WO1995006417A1 (en) 1995-03-09

Family

ID=8154412

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1994/000258 WO1995006417A1 (en) 1993-09-02 1994-06-24 Dietary supplement based on soluble dietary fibers

Country Status (5)

Country Link
EP (1) EP0802737A1 (en)
AU (1) AU7121594A (en)
CA (1) CA2170864A1 (en)
DK (1) DK9300398U3 (en)
WO (1) WO1995006417A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042206A1 (en) * 1997-03-25 1998-10-01 Savas S.A.S. Edulcorating soluble composition containing alimentary fibres, its preparation and use for alimentary purpose
WO2000074501A1 (en) * 1999-06-07 2000-12-14 Fibersugar Aps Particulate fibre composition
WO2003090558A1 (en) * 2002-04-24 2003-11-06 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
WO2005079603A1 (en) * 2004-02-20 2005-09-01 Novartis Consumer Health S.A. Dietary fiber composition
US20100143509A1 (en) * 2008-08-01 2010-06-10 University Of The West Indies, A Regional Institution, Established By Royal Charter Therapeutic compositions from jamaican bitter yam and methods of making and using same
US8062686B2 (en) 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735814A (en) * 1986-06-09 1988-04-05 Conagra, Inc. Process for modifying bran
WO1993007767A1 (en) * 1991-10-21 1993-04-29 The Procter & Gamble Company Unflavored psyllium drink mix compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735814A (en) * 1986-06-09 1988-04-05 Conagra, Inc. Process for modifying bran
WO1993007767A1 (en) * 1991-10-21 1993-04-29 The Procter & Gamble Company Unflavored psyllium drink mix compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIALOG INFORMATION SERVICE, File 351, WPI, Dialog Accession No. 004157192, WPI Accession No. 84-302731/49, (BEZZ/), "High-Fibre Granulate or Tablets With Controlled Swelling Capacity From Homogenised Fibrous Substances With Gelling Agents and Aroma Additives"; & HU,A,33 032, (29-10-84). *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042206A1 (en) * 1997-03-25 1998-10-01 Savas S.A.S. Edulcorating soluble composition containing alimentary fibres, its preparation and use for alimentary purpose
US7897177B2 (en) 1999-06-07 2011-03-01 Medic House Cambrige Ltd Particulate fibre composition
WO2000074501A1 (en) * 1999-06-07 2000-12-14 Fibersugar Aps Particulate fibre composition
WO2003090558A1 (en) * 2002-04-24 2003-11-06 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US8568767B2 (en) 2004-02-20 2013-10-29 Novartis Ag Dietary fiber composition
US8062659B2 (en) 2004-02-20 2011-11-22 Novartis Ag Dietary fiber composition
US8372426B2 (en) 2004-02-20 2013-02-12 Novartis Consumer Health S.A. Dietary fiber composition
WO2005079603A1 (en) * 2004-02-20 2005-09-01 Novartis Consumer Health S.A. Dietary fiber composition
US8062686B2 (en) 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
US10010102B2 (en) 2005-04-12 2018-07-03 Inovobiologic Inc. Dietary supplement and methods of use
US20100143509A1 (en) * 2008-08-01 2010-06-10 University Of The West Indies, A Regional Institution, Established By Royal Charter Therapeutic compositions from jamaican bitter yam and methods of making and using same
US10369183B2 (en) * 2008-08-01 2019-08-06 University Of The West Indies Therapeutic compositions from jamaican bitter yam and methods of making and using same

Also Published As

Publication number Publication date
EP0802737A1 (en) 1997-10-29
AU7121594A (en) 1995-03-22
DK9300398U3 (en) 1993-12-24
CA2170864A1 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
US6245326B1 (en) Health supplement
US4784861A (en) Weight-control formulation
US5118510A (en) Niacin drink mix formulation
US5149541A (en) Psyllium-containing produces with a distribution of particle size
EP2138055B1 (en) Formula food to be beneficial for visuognosis persistence and use thereof
EP1075836A2 (en) Skin care of food composition containing N-acetyl-glucosamine
JP4771882B2 (en) Composition having action of treating, preventing or ameliorating diabetes or diabetic complication and beverage containing the same
GB2262888A (en) Inhibitor for absorption of digested and decomosed products of food and drink
JPH0745521B2 (en) Antihypertensive agent having antihypertensive effect
FI100304B (en) A process for preparing a therapeutically useful psyllium shell
GB1590507A (en) Method of controlling fecal output and compositions therefor
JP3720496B2 (en) Novel pectin and emulsion containing the same
JP2779616B1 (en) Dietary fiber-containing composition
WO1995006417A1 (en) Dietary supplement based on soluble dietary fibers
DE69823546T3 (en) PROCESS FOR ACCELERATING THE DIGESTION OF A PROTEIN AND MODIFIED PROTEIN PRODUCT
EP1008306B1 (en) Polysaccharide which can reduce viscosity resulting from psyllium, and foods containing the polysaccharide and psyllium
EP0241710B1 (en) Flour of guar
CN112042939A (en) Chewable tablet for supplementing retina nutrition
JP2008120771A (en) Ameliorating agent for constipation
CA2030448A1 (en) Niacin drink mix formulation
JP2001316274A (en) Tube feeding nutriment and method for producing the same
CN110810605A (en) Sweet orange lutein ester tablet for children to eat
CA2098199C (en) Psyllium and cholestyramine compositions with improved palatability
CN108935690A (en) A kind of aloe milk effervescent tablet and preparation method thereof
AU747388B2 (en) Health supplement

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB HU JP KP KR KZ LK LU LV MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2170864

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1994920413

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 268340

Country of ref document: NZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 1996 604939

Country of ref document: US

Date of ref document: 19960712

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1994920413

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994920413

Country of ref document: EP